Pernix Therapeutics Balance Sheet - Annual (NASDAQ:PTX)

Add to My Stocks
$2.49 $0.04 (1.63%) PTX stock closing price Jun 18, 2018 (Closing)

The Pernix Therapeutics balance sheet is a snapshot of the company's financial health at a given point of time, whereas the other two financial statements are for a particular accounting period. All three financial statements should be used to measure the financial performance of the company, and should form a part of the Pernix Therapeutics stock analysis. Good annual results indicate a company's strong financial performance. Its important to check all financial statements including the balance sheet. Pernix Therapeutics had a long term debt of $214.24M at the end of 2017. To understand the debt servicing capacity of the company, one needs to look at Pernix Therapeutics operating cash flow and Pernix Therapeutics revenue also. Pernix Therapeutics debt to equity ratio is -.

View latest 10 year balance sheet data to check Pernix Therapeutics financial performance.
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec2017201620152014201320122011201020092008
Cash32.82M36.37M66.13M34.85M15.64M23.02M34.55M8.76M6.71M8M
Marketable Securities----------
Receivables45.44M52.14M67.94M44.12M25.68M36.64M20.6M14.75M--
Inventory5.39M7.77M10.03M11.36M13.8M22.01M6.26M4.14M--
Raw Materials-2.36M2.04M-2.3M11.01M----
Work In Progress--1.42M-------
Finished Goods5.88M7.39M9.01M12.2M13.41M11.26M5.84M4.14M--
Notes Receivable---4.72M4.74M-----
Other Current Assets10.11M12.61M13.28M34.19M16.49M14.03M6.69M4.31M--
Total Current Assets
93.77M108.91M157.39M129.25M76.38M95.71M68.1M32.09M6.87M8.56M
Property Plant & Equipment1.66M1.8M2.81M1.69M7.98M7.42M1.23M1.43M-1.05M
Accumulated Depreciation----1.11M-----
Net Property Plant & Equipment
-1.1M2.34M1.51M6.87M6.94M-1.21M-1.04M
Investment & Advances-----5.71M4.45M1.5M--
Other Non-Current Assets----4.53M----4.13M
Deferred Charges----------
Intangibles108.7M200.17M340.8M345.38M122.51M141.21M8.87M10.96M--
Deposits & Other Assets2.26M-10.6M11.25M1.07M1.85M----
Total Assets
205.49M310.44M511.15M487.41M211.38M251.44M82.56M46.03M7.96M13.75M
Notes Payable3.66M11.1M15.04M-------
Accounts Payable7.91M7.27M14.08M5.39M3.44M5.04M2.98M2.24M--
Current Portion Long-Term Debt---7.34M16.99M2.28M6M---
Current Portion Capital Leases----------
Accrued Expenses68.96M75.02M76.36M71.5M43.62M38.48M20.61M12.65M--
Income Taxes Payable----------
Other Current Liabilities13.26M16.12M28.65M13.42M5.4M8.13M1.87M4.34M-4.69M
Total Current Liabilities
93.8M109.52M134.15M97.67M69.46M53.94M31.48M19.25M-4.78M
Mortgages----------
Deferred Taxes/Income---9.38M15.49M35.53M-1.07M--
Convertible Debt65.73M104.07M103.8M65M------
Long-Term Debt214.24M14M209.94M220M1.3M41.34M-5M--
Non-Current Capital Leases----------
Other Long-Term Liabilities5.97M196.9M29.95M11.75M14.38M42.07M-1.8M--
Total Liabilities
379.74M424.5M478.06M403.82M100.66M172.9M32.94M27.12M-5.59M
Minority Interest----------
Preferred Stock----------
Common Stock Net----------
Capital Surplus261.15M244.3M226.83M129.12M119.55M58.6M30.18M8.93M8.98M8.8M
Retained Earnings-435.53M-358.39M-188.8M-40.48M-5.2M20.43M21.84M13.49M-1.24M-0.72M
Treasury Stock--5.54M5.43M4M3.77M3.75M3.75M--
Other Liabilities--0.07M---2.97M1.08M---
Shareholders Equity-174.25M-114.06M33.09M83.59M110.72M78.53M49.62M18.9M7.81M8.15M
Total Liabilities & Shareholders Equity205.49M310.44M511.15M487.41M211.38M251.44M82.56M46.03M7.96M13.75M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Most investors just check the Pernix Therapeutics stock price, and Pernix Therapeutics historical stock prices before investing. While share price is an important factor, one should also look at financials and valuation metrics like the Pernix Therapeutics PE ratio chart. Below is a brief explanation of common balance sheet terms:

  • Assets: PTX total assets, which was at $205.49M for 2017 is a balance sheet item representing value of what Pernix Therapeutics owns. Assets are brought to aid a firms operations, or to increase its economic value. It must be noted that tech stocks may not have a lot of assets, as the value for these companies is often derived from future earning potential.
  • Liabilities: This item on the balance sheet implies the firm's, in this case Pernix Therapeutics's, legal obligations including loans, accounts payable, deferred revenue, accrued expenses and mortgages. The total liabilities for PTX stock stand at $379.74M.

Pernix Therapeutics Balance Sheet - Key Ratios

Current ratio
0.88
Debt to equity ratio
0
Asset turnover ratio
0.59
Receivables turnover
3.46